iifl-logo-icon 1

Ortin Laboratories Ltd Share Price

19.07
(-0.31%)
Jul 18, 2024|03:32:01 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open19.96
  • Day's High19.96
  • 52 Wk High26.35
  • Prev. Close19.13
  • Day's Low19
  • 52 Wk Low16.2
  • Turnover (lac)1.55
  • P/E0
  • Face Value10
  • Book Value3.47
  • EPS0
  • Mkt. Cap (Cr.)15.51
  • Div. Yield0
No Records Found

Ortin Laboratories Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

19.96

Prev. Close

19.13

Turnover(Lac.)

1.55

Day's High

19.96

Day's Low

19

52 Week's High

26.35

52 Week's Low

16.2

Book Value

3.47

Face Value

10

Mkt Cap (₹ Cr.)

15.51

P/E

0

EPS

0

Divi. Yield

0

Ortin Laboratories Ltd Corporate Action

13 Feb 2024

12:00 AM

EGM

arrow

6 Sep 2023

12:00 AM

AGM

Announcement Date: 06 Sep, 2023

arrow

22 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

12 Sep 2023

12:00 AM

BookCloser

arrow

Ortin Laboratories Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Ortin Laboratories Ltd SHAREHOLDING SNAPSHOT

18 Jul, 2024|05:34 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 1.23%

Foreign: 0.00%

Indian: 1.23%

Non-Promoter- 98.76%

Institutions: 0.00%

Non-Institutions: 98.76%

Custodian: 0.00%

Share Price

Ortin Laboratories Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

8.13

8.13

8.13

16.94

Preference Capital

0

0

0

0

Reserves

2.73

2.83

3.22

6.88

Net Worth

10.86

10.96

11.35

23.82

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

8.16

197.39

79.71

61.88

yoy growth (%)

-95.86

147.63

28.8

-1.67

Raw materials

-3.95

-154.62

-57.59

-40.72

As % of sales

48.36

78.33

72.24

65.8

Employee costs

-1.05

-5.35

-3.32

-3.34

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

0.13

0.71

0.68

1.13

Depreciation

-0.28

-1.95

-1.68

-1.7

Tax paid

0.8

-1.28

0

-0.62

Working capital

-19.52

-3.33

2.94

3.15

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

-95.86

147.63

28.8

-1.67

Op profit growth

-78.18

5.72

-0.76

-7.62

EBIT growth

-74.28

-5.76

2.65

-15.72

Net profit growth

-267.66

-183.02

34.97

-39.65

View Ratios
Particulars (Rupees in Crores.)Mar-2012

Gross Sales

78.91

Excise Duty

0

Net Sales

78.91

Other Operating Income

6.88

Other Income

0.25

Ortin Laboratories Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,579.3

124.153,78,914.98867.60.855,536.9998.75

Cipla Ltd

CIPLA

1,510.4

32.861,22,044.231,038.40.563,444.92346.41

Divis Laboratories Ltd

DIVISLAB

4,570.8

76.931,21,185.085310.662,259507.93

Zydus Lifesciences Ltd

ZYDUSLIFE

1,184.8

34.691,19,223.631,405.20.253,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,646.05

25.871,10,827.471,034.80.65,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Ortin Laboratories Ltd

Management

Register Office

Registrar Office

Managing Director

S Murali Krishna Murthy

Director

S Balaji Venkateswarlu

Whole Time Director & CFO

S Srinivas Kumar

Chairman & Independent Directo

J R K Panduranga Rao

Director

Gaddam Venkata Ramana

Director

Bhupathiraju S Raju

Independent Director

B Gopal Reddy

Independent Director

Murali Krishna Rayaprolu

Independent Director

Pottur Sujatha

Company Sec. & Compli. Officer

Divya Purswani

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Ortin Laboratories Limited was incorporated in October, 1986 with a nominal capital of Rs 1 lakh to offer quality Drugs and Medicines to the suffering mankind. The Company is a leading and predominant Pharmaceutical Manufacturer of Drugs and Medicines in India. The company is engaged in manufacture of Pharma formulations. They manufacture a range of pharmaceutical formulations of tablets, capsules, syrups, dry powders, and ointments in India. The company is having their manufacturing unit at Medak in Andhra Pradesh, which is equipped with technically modern manufacturing facilities to produce complete range of Pharmaceutical Formulations.The company offer anti arthritic drugs, antibiotics, chemo therapeutics, analgesics and antipyretics, cardiac and cardio vascular drugs, anti diarroheal drugs, anti depressants, anti hypertensive, anti aids, anti tuberculosis drugs, gynaecological drugs, antibiotics, anti diabetic, antacids anti ulcer drugs, anti allergics, anti-cold, decongestants, antioxidents, vitamins, minerals, anti bacterial drugs, anti emetics, anti helmenthetics, nutritional supplements and protein, and appetizers. They also produce dental, ophthalmology, pediatric, diuretics, dermatology, psychiatry, and ENT drugs. The company constructed a Factory in a spacious area of 25,000 sq feet with all ultra-modern infrastructure as per the WHO GMP Standards to manufacture the complete range of Pharmaceutical Formulations of tablets capsules syrups dry powders & ointments. Du
Read More

Company FAQs

What is the Ortin Laboratories Ltd share price today?

Down Arrow

The Ortin Laboratories Ltd shares price on N/A is Rs.₹19.15 today.

What is the Market Cap of Ortin Laboratories Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Ortin Laboratories Ltd is ₹15.57 Cr. as of 18 Jul ‘24

What is the PE and PB ratio of Ortin Laboratories Ltd?

Down Arrow

The PE and PB ratios of Ortin Laboratories Ltd is 0 and 5.44 as of 18 Jul ‘24

What is the 52 Week High and Low of Ortin Laboratories Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Ortin Laboratories Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Ortin Laboratories Ltd is ₹16.15 and ₹26.39 as of 18 Jul ‘24

What is the CAGR of Ortin Laboratories Ltd?

Down Arrow

Ortin Laboratories Ltd's CAGR for 5 Years at 9.75%, 3 Years at -19.63%, 1 Year at -7.50%, 6 Month at -11.78%, 3 Month at -3.23% and 1 Month at -8.53%.

What is the shareholding pattern of Ortin Laboratories Ltd?

Down Arrow

The shareholding pattern of Ortin Laboratories Ltd is as follows:
Promoters - 1.23 %
Institutions - 0.00 %
Public - 98.77 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.